Retension Pharmaceuticals, Inc. RTSN
IPO
NASDAQ
Corporate Info
Website
Phone Number
(703) 940-9761
Address
1104 West Broad Street #1029
Falls Church, VA 22046
Falls Church, VA 22046
Country
United States
Year Founded
2023
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
12
Business Description
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The Company operates as a single operating and reportable segment focused on the development of treatments for hypertension and cardiovascular disease. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.